Taking sharper aim at stomach ulcer bacteria
Key points
- Scientists are reporting discovery of a much sought after crack in the armor of a common microbe that infects the stomachs of one-sixth of the world's population, causing stomach ulcers and other diseases.
- Javier Sancho and colleagues note in the new study that Helicobacter pylori ( H. pylori ) bacteria infect the stomach lining and can cause gastritis and ulcers.
- The scientists knew from past research that blocking flavodoxin, a key protein that H. pylori needs for survival, could be the key to developing narrow-spectrum antibiotics that specifically target H. pylori.
- They then showed that three of the four substances killed H. pylori in cell cultures and did not have any apparent toxic effects in lab animals.
Scientists are reporting discovery of a much sought after crack in the armor of a common microbe that infects the stomachs of one-sixth of the world's population, causing stomach ulcers and other diseases. They identified a group of substances that block a key chemical pathway that the bacteria need for survival. Their study, which could lead to new, more effective antibiotics to fight these hard-to-treat microbes, is scheduled for the October 16 issue of ACS Chemical Biology, a monthly journal.
Javier Sancho and colleagues note in the new study that Helicobacter pylori ( H. pylori ) bacteria infect the stomach lining and can cause gastritis and ulcers. Treatment with broad-spectrum antibiotics can cure H. pylori infections. However, an estimated one billion people remain infected worldwide because of the cost of existing antibiotics and the emergence of antibiotic resistant strains of the bacteria, the researchers say.
The scientists knew from past research that blocking flavodoxin, a key protein that H. pylori needs for survival, could be the key to developing narrow-spectrum antibiotics that specifically target H. pylori. Sancho's team screened 10,000 chemicals for their ability to block flavodoxin and identified four that showed promise.
They then showed that three of the four substances killed H. pylori in cell cultures and did not have any apparent toxic effects in lab animals. "These new inhibitors constitute promising candidates to develop new specific antibiotics against H. pylori," the study states.
###
ARTICLE #3 FOR IMMEDIATE RELEASE
"Discovery of specific flavodoxin inhibitors as potential therapeutic agents against Helicobacter pylori infection"
DOWNLOAD FULL TEXT ARTICLE http://pubs.acs.org/stoken/presspac/presspac/full/10.1021/cb900166q
CONTACT:
Javier Sancho, Ph.D.
Zaragoza University
Department of Biochemistry, Molecular, and Cell Biology
Zaragoza, Spain
Phone: 34 976761286
Fax: 34 976762123
Email: jsancho@unizar.es
Contact: Michael Woods
m_woods@acs.org
202-872-6293
American Chemical Society
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Digestive Health →NewsPhysician Definitively Links Irritable Bowel Syndrome (IBS) and Bacteria in Gut
An overgrowth of bacteria in the gut has been definitively linked to Irritable Bowel Syndrome in the results of a new Cedars-Sinai study which used cultures from the small intestine. This is the first study to use this…
29 May 2012
NewsCedars-Sinai physician definitively links irritable bowel syndrome and bacteria in gut
An overgrowth of bacteria in the gut has been definitively linked to Irritable Bowel Syndrome in the results of a new Cedars-Sinai study which used cultures from the small intestine. This is the first study to use this…
25 May 2012
NewsTakeda drug impresses in ulcerative colitis study
More than 40 percent of patients with moderate to severe ulcerative colitis achieved clinical remission from the debilitating condition after a year of taking an experimental drug developed by Japan's Takeda…